364 related articles for article (PubMed ID: 14579518)
1. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
Pardridge WM
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier genomics.
Li JY; Boado RJ; Pardridge WM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):61-8. PubMed ID: 11149669
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier delivery.
Pardridge WM
Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
[TBL] [Abstract][Full Text] [Related]
4. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
5. Understanding the blood-brain barrier using gene and protein expression profiling technologies.
Pottiez G; Flahaut C; Cecchelli R; Karamanos Y
Brain Res Rev; 2009 Dec; 62(1):83-98. PubMed ID: 19770003
[TBL] [Abstract][Full Text] [Related]
6. The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
Tachikawa M; Kasai Y; Yokoyama R; Fujinawa J; Ganapathy V; Terasaki T; Hosoya K
J Neurochem; 2009 Oct; 111(2):499-509. PubMed ID: 19682207
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
Allen DD; Geldenhuys WJ
Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
[TBL] [Abstract][Full Text] [Related]
8. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
9. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery.
Calabria AR; Shusta EV
Drug Discov Today; 2006 Sep; 11(17-18):792-9. PubMed ID: 16935746
[TBL] [Abstract][Full Text] [Related]
11. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
[TBL] [Abstract][Full Text] [Related]
12. Pattern of glucose transporter (Glut 1) expression in embryonic brains is related to maturation of blood-brain barrier tightness.
Dermietzel R; Krause D; Kremer M; Wang C; Stevenson B
Dev Dyn; 1992 Feb; 193(2):152-63. PubMed ID: 1581603
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of the blood-brain barrier.
Pardridge WM
Mol Biotechnol; 2005 May; 30(1):57-70. PubMed ID: 15805577
[TBL] [Abstract][Full Text] [Related]
14. The rat blood-brain barrier transcriptome.
Enerson BE; Drewes LR
J Cereb Blood Flow Metab; 2006 Jul; 26(7):959-73. PubMed ID: 16306934
[TBL] [Abstract][Full Text] [Related]
15. Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2.
Li JY; Boado RJ; Pardridge WM
J Cereb Blood Flow Metab; 2001 Aug; 21(8):929-36. PubMed ID: 11487728
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
Pardridge WM
Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic renal failure on brain drug transporters in rats.
Naud J; Laurin LP; Michaud J; Beauchemin S; Leblond FA; Pichette V
Drug Metab Dispos; 2012 Jan; 40(1):39-46. PubMed ID: 21969519
[TBL] [Abstract][Full Text] [Related]
20. Strategies to optimize brain penetration in drug discovery.
Liu X; Chen C
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):505-12. PubMed ID: 16022187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
